Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with P...
Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18F-flutemetamol and 18F-florbetaben
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Although amyloid beta (A[beta]) imaging is widely used for diagnosing and monitoring Alzheimer's disease in clinical fields, paralleling comparison between .sup.18F-flutemetamol and .sup.18F-florbetaben was rarely attempted in AD mouse model. We performed a comparison of A[beta] PET images between .sup.18F-flutemetamol and .sup.18F-florb...
Alternative Titles
Full title
Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18F-flutemetamol and 18F-florbetaben
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_47e2f36de06a4141a3913afa279c890d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_47e2f36de06a4141a3913afa279c890d
Other Identifiers
ISSN
1471-2202
E-ISSN
1471-2202
DOI
10.1186/s12868-018-0447-7
